NEWARK, Del.–(BUSINESS WIRE)–CSols, Inc. the premier Laboratory Informatics consultancy, announced
the successful completion of the enhancement and extension of GenoLogics
Clarity Lab Information Management System (LIMS) for Adaptive
Biotechnologies, the leader in high-throughput immunosequencing. To make
use of several new features, and to further automate the processing and
management of its assays, Adaptive Biotechnologies decided to upgrade
its GenoLogics Clarity LIMS. In scoping the requirements for this
upgrade, Adaptive Biotechnologies realized that some enhancements,
extensions, and interfaces (instruments and systems) were needed, and
turned to CSols, a Clarity Certified Application Development (CCAD)
partner, for assistance.
Adaptive engaged CSols to develop the enhancements, extensions, and
interfaces, because of CSols’ expertise with Clarity LIMS, the Clarity
LIMS API, and its laboratory and domain knowledge.
“CSols was fantastic to work with,” said Sean Nolan, chief technology
officer of Adaptive Biotechnologies. “Their consultants were exactly
what we needed.”
The project was completed successfully, on time and within budget.
Consequently, Adaptive Biotechnologies was able to realize many benefits
- Increased usability, functionality, quality, and productivity by
leveraging CSols Clarity LIMS API and domain expertise to facilitate
the upgrade of GenoLogics Clarity
- Increased levels of automation and integration yielding greater
efficiency and laboratory throughput
- Attained a high level of system adoption and utilization through the
tailoring of functionality to fit Adaptive’s needs, without altering
current work processes and methods
The full Project Case Study can be downloaded
About CSols, Inc.
CSols, Inc. is the premier Laboratory Informatics Consultancy, providing
objective guidance and tailored solutions through their services:
strategic planning and vendor selection, implementation and enhancement,
and computer system validation. For more information, visit www.csolsinc.com.
About Adaptive Biotechnologies®
Adaptive Biotechnologies is the pioneer and leader in combining
high-throughput sequencing and expert bioinformatics to profile T-cell
and B-cell receptors. Adaptive is bringing the accuracy and sensitivity
of its immunosequencing platform into laboratories around the world to
drive groundbreaking research in cancer and other immune-mediated
diseases. Adaptive also translates immunosequencing discoveries into
clinical diagnostics and therapeutic development to improve patient
care. For more information, visit adaptivebiotech.com.
Megan Cavanaugh, 302-731-5290